Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Influenza

Free Subscription 29.11.2021 3 Ann Intern Med 1 Antimicrob Agents Chemother 1 Biochem Soc Trans 1 BMC Pediatr 11 BMJ 1 Cell 3 Epidemiol Infect 11 J Clin Microbiol 1 J Exp Med 1 J Gen Virol 1 J Immunol 2 J Infect Dis 1 J Virol 23 J Virol Methods 10 JAMA 5 Lancet 3 N Engl J Med 2 Pediatrics 4 PLoS Comput Biol 30 PLoS One 2 Proc Natl Acad Sci U S A 14 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Intern Med

1. BARRETT E, Hingle ST, Smith CD, Moyer DV, et al
   Getting Through COVID-19: Keeping Clinicians in the Workforce.
   Ann Intern Med. 2021 Sep 28. doi: 10.7326/M21-3381.
   PubMed        
   
   
2. MOGHADAS SM, Sah P, Shoukat A, Meyers LA, et al
   Population Immunity Against COVID-19 in the United States.
   Ann Intern Med. 2021 Sep 14. doi: 10.7326/M21-2721.
   PubMed         Abstract available
   
   
3. PALTIEL AD, Schwartz JL
   Assessing COVID-19 Prevention Strategies to Permit the Safe Opening of Residential Colleges in Fall 2021.
   Ann Intern Med. 2021 Aug 31. doi: 10.7326/M21-2965.
   PubMed         Abstract available
   
   

   
   Antimicrob Agents Chemother

4. TIETJEN I, Cassel J, Register ET, Zhou XY, et al
   The Natural Stilbenoid (-)-Hopeaphenol Inhibits Cellular Entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7, and B.1.351 Variants.
   Antimicrob Agents Chemother. 2021;65:e0077221.
   PubMed         Abstract available
   
   

   
   Biochem Soc Trans

5. ZASLONA ME, Downey AM, Seeberger PH, Moscovitz O, et al
   Semi- and fully synthetic carbohydrate vaccines against pathogenic bacteria: recent developments.
   Biochem Soc Trans. 2021;49:2411-2429.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

6. ACEVEDO L, Pineres-Olave BE, Nino-Serna LF, Vega LM, et al
   Mortality and clinical characteristics of multisystem inflammatory syndrome in children (MIS-C) associated with covid-19 in critically ill patients: an observational multicenter study (MISCO study).
   BMC Pediatr. 2021;21:516.
   PubMed         Abstract available
   
   

   
   BMJ

7. GUZMAN-PRADO Y
   PPE: producing polluted environment.
   BMJ. 2021;375:n2822.
   PubMed        
   
   
8. CAAN W
   Parliamentary committee report on covid-19 response: the difference between an apology and repentance.
   BMJ. 2021;375:n2813.
   PubMed        
   
   
9. ALTMANN D, Boyton R
   Covid-19 caseload in the UK-assessments and mitigations.
   BMJ. 2021;375:n2843.
   PubMed        
   
   
10. BANERJEE A
    Long covid: new wine in need of new bottles.
    BMJ. 2021;375:n2736.
    PubMed        
    
    
11. VAN SCHALKWYK JM
    New Zealand's covid-19 policy switch will harm vulnerable people.
    BMJ. 2021;375:n2738.
    PubMed        
    
    
12. MOON J, Wenham C, Harman S
    SAGO has a politics problem, and WHO is ignoring it.
    BMJ. 2021;375:n2786.
    PubMed        
    
    
13. PATTERSON L
    Encouraging covid vaccine uptake and safe behaviours-an uphill struggle against government complacency.
    BMJ. 2021;375:n2773.
    PubMed        
    
    
14. BHUTTA ZA, Mitra A, Salman A, Akbari F, et al
    Conflict, extremism, resilience and peace in South Asia; can covid-19 provide a bridge for peace and rapprochement?
    BMJ. 2021;375:e067384.
    PubMed        
    
    
15. DEVNANI M
    Covid-19 and laws for workplace violence in healthcare.
    BMJ. 2021;375:n2776.
    PubMed        
    
    
16. TALIC S, Shah S, Wild H, Gasevic D, et al
    Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis.
    BMJ. 2021;375:e068302.
    PubMed         Abstract available
    
    
17. GLASZIOU PP, Michie S, Fretheim A
    Public health measures for covid-19.
    BMJ. 2021;375:n2729.
    PubMed        
    
    

    
    Cell

18. PAYNE RP, Longet S, Austin JA, Skelly DT, et al
    Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine.
    Cell. 2021;184:5699-5714.
    PubMed         Abstract available
    
    

    
    Epidemiol Infect

19. BAYS D, Bennett E, Finnie T
    What effect might border screening have on preventing the importation of COVID-19 compared with other infections? A modelling study.
    Epidemiol Infect. 2021;149:e238.
    PubMed         Abstract available
    
    
20. ABU JABAL K, Ben-Amram H, Beiruti K, Brimat I, et al
    SARS-CoV-2 immunogenicity in individuals infected before and after COVID-19 vaccination: Israel, January-March 2021.
    Epidemiol Infect. 2021;149:e239.
    PubMed         Abstract available
    
    
21. TATSI EB, Filippatos F, Michos A
    SARS-CoV-2 variants and effectiveness of vaccines: a review of current evidence.
    Epidemiol Infect. 2021;149:e237.
    PubMed         Abstract available
    
    

    
    J Clin Microbiol

22. JEONG S, Lee N, Lee SK, Cho EJ, et al
    Comparison of the Results of Five SARS-CoV-2 Antibody Assays before and after the First and Second ChAdOx1 nCoV-19 Vaccinations among Health Care Workers: a Prospective Multicenter Study.
    J Clin Microbiol. 2021;59:e0178821.
    PubMed         Abstract available
    
    
23. BABIKER A, Immergluck K, Stampfer SD, Rao A, et al
    Single-Amplicon Multiplex Real-Time Reverse Transcription-PCR with Tiled Probes To Detect SARS-CoV-2 spike Mutations Associated with Variants of Concern.
    J Clin Microbiol. 2021;59:e0144621.
    PubMed         Abstract available
    
    
24. KRUSE RL, Huang Y, Lee A, Zhu X, et al
    A Hemagglutination-Based Semiquantitative Test for Point-of-Care Determination of SARS-CoV-2 Antibody Levels.
    J Clin Microbiol. 2021;59:e0118621.
    PubMed         Abstract available
    
    
25. TROBAJO-SANMARTIN C, Miqueleiz A, Portillo ME, Fernandez-Huerta M, et al
    Emergence of SARS-CoV-2 Variant B.1.575.2, Containing the E484K Mutation in the Spike Protein, in Pamplona, Spain, May to June 2021.
    J Clin Microbiol. 2021;59:e0173621.
    PubMed         Abstract available
    
    
26. ERGUN M, Bruggemann RJM, Alanio A, Delliere S, et al
    Aspergillus test profiles and mortality in critically-ill COVID-19 patients.
    J Clin Microbiol. 2021 Sep 8:JCM0122921. doi: 10.1128/JCM.01229.
    PubMed         Abstract available
    
    
27. LEUZINGER K, Osthoff M, Drager S, Pargger H, et al
    Comparing Immunoassays for SARS-CoV-2 Antibody Detection in Patients with and without Laboratory-Confirmed SARS-CoV-2 Infection.
    J Clin Microbiol. 2021;59:e0138121.
    PubMed         Abstract available
    
    
28. PLITNICK J, Griesemer S, Lasek-Nesselquist E, Singh N, et al
    Whole-Genome Sequencing of SARS-CoV-2: Assessment of the Ion Torrent AmpliSeq Panel and Comparison with the Illumina MiSeq ARTIC Protocol.
    J Clin Microbiol. 2021;59:e0064921.
    PubMed         Abstract available
    
    
29. GRAF EH
    Finding the Middle Ground with the Clinical Laboratory's Role in SARS-CoV-2 Genomic Surveillance.
    J Clin Microbiol. 2021;59:e0181621.
    PubMed         Abstract available
    
    
30. ARMSTRONG DT, Tacheny EA, Olinger G, Howard R, et al
    SARS-CoV-2 Supply Shortages and Tuberculosis Diagnostics: Current Issues Requiring Immediate Solutions.
    J Clin Microbiol. 2021;59:e0077821.
    PubMed         Abstract available
    
    
31. YANSON K, Laviers W, Neely L, Lockamy E, et al
    Performance Evaluation of the BD SARS-CoV-2 Reagents for the BD MAX System.
    J Clin Microbiol. 2021;59:e0101921.
    PubMed         Abstract available
    
    
32. STOKES NL, Reed KA, Berbari EF, Vetter S, et al
    Evaluation of the BinaxNOW COVID-19 Rapid Antigen Test in an Asymptomatic Patient Population Undergoing Preprocedural Screening.
    J Clin Microbiol. 2021;59:e0165021.
    PubMed        
    
    

    
    J Exp Med

33. MAO T, Israelow B, Lucas C, Vogels CBF, et al
    A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in mice.
    J Exp Med. 2022;219.
    PubMed         Abstract available
    
    

    
    J Gen Virol

34. VIANA K, Zarpelon L, Leandro A, Terencio M, et al
    Infection in asymptomatic carriers of SARS-CoV-2 can interfere with the achievement of robust immunity on a population scale.
    J Gen Virol. 2021;102.
    PubMed         Abstract available
    
    

    
    J Immunol

35. HUSSAIN SA, Rohlfing M, Resiliac J, Santoro J, et al
    Atopic Neutrophils Prevent Postviral Airway Disease.
    J Immunol. 2021;207:2589-2597.
    PubMed         Abstract available
    
    

    
    J Infect Dis

36. LEWIS AM, Zhang X, Brestoff JR
    Coronavirus Disease 2019 Severity in Obese Patients May Be Linked to Viral Load and Immune Response.
    J Infect Dis. 2021;224:1449-1451.
    PubMed        
    
    
37. CODY MEISSNER H
    Approaching the End of the Era of Uncontrolled Respiratory Syncytial Virus Disease.
    J Infect Dis. 2021;223:737-739.
    PubMed        
    
    

    
    J Virol

38. ZHANG H, Zheng H, Guo P, Hu L, et al
    Correction for Zhang et al., "Broadly Protective CD8(+) T Cell Immunity to Highly Conserved Epitopes Elicited by Heat Shock Protein gp96-Adjuvanted Influenza Monovalent Split Vaccine".
    J Virol. 2021;95:e0175021.
    PubMed        
    
    

    
    J Virol Methods

39. SHAH SR, Kane SR, Elsheikh M, Alfaro TM, et al
    Development of a rapid viability RT-PCR (RV-RT-PCR) method to detect infectious SARS-CoV-2 from swabs.
    J Virol Methods. 2021;297:114251.
    PubMed         Abstract available
    
    
40. MANENTI A, Molesti E, Maggetti M, Torelli A, et al
    The theory and practice of the viral dose in neutralization assay: Insights on SARS-CoV-2 "doublethink" effect.
    J Virol Methods. 2021;297:114261.
    PubMed         Abstract available
    
    
41. WEHRENDT DP, Masso MG, Gonzales Machuca A, Vargas CV, et al
    A rapid and simple protocol for concentration of SARS-CoV-2 from sewage.
    J Virol Methods. 2021;297:114272.
    PubMed         Abstract available
    
    
42. RIESTER E, Findeisen P, Hegel JK, Kabesch M, et al
    Performance evaluation of the Roche Elecsys Anti-SARS-CoV-2 S immunoassay.
    J Virol Methods. 2021;297:114271.
    PubMed         Abstract available
    
    
43. BARONTI C, Coutard B, de Lamballerie X, Charrel R, et al
    Evaluation of formulations to improve SARS-CoV-2 viability and thermostability after lyophilisation.
    J Virol Methods. 2021;297:114252.
    PubMed         Abstract available
    
    
44. SALVO M, Moller A, Alvareda E, Gamazo P, et al
    Evaluation of low-cost viral concentration methods in wastewaters: Implications for SARS-CoV-2 pandemic surveillances.
    J Virol Methods. 2021;297:114249.
    PubMed         Abstract available
    
    
45. BLAIRON L, Cupaiolo R, Piteus S, Beukinga I, et al
    The challenge of screening SARS-CoV-2 variants of concern with RT-qPCR: One variant can hide another.
    J Virol Methods. 2021;297:114248.
    PubMed         Abstract available
    
    
46. CIESIELSKI M, Blackwood D, Clerkin T, Gonzalez R, et al
    Assessing sensitivity and reproducibility of RT-ddPCR and RT-qPCR for the quantification of SARS-CoV-2 in wastewater.
    J Virol Methods. 2021;297:114230.
    PubMed         Abstract available
    
    
47. MARIEN J, Michiels J, Heyndrickx L, Nkuba-Ndaye A, et al
    Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2.
    J Virol Methods. 2021;297:114228.
    PubMed         Abstract available
    
    
48. VELASCO JM, Shrestha S, Valderama MT, Shrestha J, et al
    A multi-country field validation of the FluChip-8G Insight Assay.
    J Virol Methods. 2021;289:114029.
    PubMed         Abstract available
    
    
49. PEREIRA OLIVEIRA G, Kroon EG
    Mouse hepatitis virus: A betacoronavirus model to study the virucidal activity of air disinfection equipment on surface contamination.
    J Virol Methods. 2021;297:114274.
    PubMed         Abstract available
    
    
50. DI CARLO D, Mazzuti L, Sciandra I, Guerrizio G, et al
    Comparison of FTD SARS-CoV-2 Assay and RealStar RT-PCR kit 1.0 for the detection of SARS-CoV-2.
    J Virol Methods. 2021;298:114276.
    PubMed         Abstract available
    
    
51. XIANG H, Wen X, Wen Y, Zhang H, et al
    Development and application of a visual microarray for synchronously detecting H5N1, H7N9 and H9N2 avian influenza virus RNA.
    J Virol Methods. 2021 Nov 19:114371. doi: 10.1016/j.jviromet.2021.114371.
    PubMed         Abstract available
    
    
52. VILLOTA SD, Nipaz VE, Carrazco-Montalvo A, Hernandez S, et al
    Alternative RNA extraction-free techniques for the real-time RT-PCR detection of SARS-CoV-2 in nasopharyngeal swab and sputum samples.
    J Virol Methods. 2021;298:114302.
    PubMed         Abstract available
    
    
53. PAUL D, Gupta A, Rooge S, Gupta E, et al
    Performance evaluation of automated chemiluminescence immunoassay based antigen detection - Moving towards more reliable ways to predict SARS-CoV-2 infection.
    J Virol Methods. 2021;298:114299.
    PubMed         Abstract available
    
    
54. BOERS SA, Mourik BC, van Bussel MJAWM, de Brouwer CS, et al
    Increasing diagnostic possibilities using the geneLEAD VIII platform for detection of SARS-CoV-2.
    J Virol Methods. 2021;298:114291.
    PubMed         Abstract available
    
    
55. GUPTA A, Soni A, Rooge S, Paul D, et al
    Syndromic approach to SARS-CoV-2 detection using QIAstat-Dx SARS-CoV-2 panel from clinical samples.
    J Virol Methods. 2021;298:114300.
    PubMed         Abstract available
    
    
56. AUPAIX A, Lazarova E, Chemais M
    A brief performance evaluation and literature review of Abbott ID Now COVID-19 rapid molecular-based test.
    J Virol Methods. 2021;298:114293.
    PubMed         Abstract available
    
    
57. KRUTTGEN A, Klingel H, Haase G, Haefner H, et al
    Evaluation of the QuantiFERON SARS-CoV-2 interferon- release assay in mRNA-1273 vaccinated health care workers.
    J Virol Methods. 2021;298:114295.
    PubMed         Abstract available
    
    
58. MRAVINEC M, Bajc G, Butala M
    Surface plasmon resonance approach to study drug interactions with SARS-CoV-2 RNA-dependent RNA polymerase highlights treatment potential of suramin.
    J Virol Methods. 2021;298:114283.
    PubMed         Abstract available
    
    
59. VALLEJO L, Martinez-Rodriguez M, Nieto-Bazan MJ, Delgado-Iribarren A, et al
    Comparative study of different SARS-CoV-2 diagnostic techniques.
    J Virol Methods. 2021;298:114281.
    PubMed         Abstract available
    
    
60. KUMAR V, Ghosh K, Chandran A, Panwar S, et al
    Multicentric evaluation of a novel point of care electrochemical ELISA platform for SARS-CoV-2 specific IgG and IgM antibody assay.
    J Virol Methods. 2021;298:114275.
    PubMed         Abstract available
    
    
61. WANG D, Wang Z, Gao Y, Wu X, et al
    Validation of the analytical performance of nine commercial RT-qPCR kits for SARS-CoV-2 detection using certified reference material.
    J Virol Methods. 2021;298:114285.
    PubMed         Abstract available
    
    

    
    JAMA

62. MARQUEZ N, Ward JA, Parish K, Saloner B, et al
    COVID-19 Incidence and Mortality in Federal and State Prisons Compared With the US Population, April 5, 2020, to April 3, 2021.
    JAMA. 2021 Oct 6. pii: 2784944. doi: 10.1001/jama.2021.17575.
    PubMed        
    
    
63. SZILAGYI PG, Thomas K, Shah MD, Vizueta N, et al
    Changes in COVID-19 Vaccine Intent From April/May to June/July 2021.
    JAMA. 2021 Oct 13. pii: 2785290. doi: 10.1001/jama.2021.18761.
    PubMed        
    
    
64. ABBASI J
    The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity.
    JAMA. 2021 Oct 21. pii: 2785530. doi: 10.1001/jama.2021.18919.
    PubMed        
    
    
65. MUNCH MW, Myatra SN, Vijayaraghavan BKT, Saseedharan S, et al
    Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial.
    JAMA. 2021 Oct 21. pii: 2785529. doi: 10.1001/jama.2021.18295.
    PubMed         Abstract available
    
    
66. RUBIN R
    Monoclonal Antibodies for COVID-19 Preexposure Prophylaxis Can't Come Fast Enough for Some People.
    JAMA. 2021 Oct 27. pii: 2785781. doi: 10.1001/jama.2021.19534.
    PubMed        
    
    
67. GRAVES JA, Baig K, Buntin M
    The Financial Effects and Consequences of COVID-19: A Gathering Storm.
    JAMA. 2021 Oct 29. pii: 2785892. doi: 10.1001/jama.2021.18863.
    PubMed        
    
    
68. ABBASI J
    Flu Vaccine Candidate Elicits Enhanced Immune Response.
    JAMA. 2021;326:1784.
    PubMed        
    
    
69. ABBASI J
    Pfizer Launches Phase 1 mRNA Flu Vaccine Trial.
    JAMA. 2021;326:1784.
    PubMed        
    
    
70. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Yassine HM, et al
    Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar.
    JAMA. 2021 Nov 1. pii: 2785918. doi: 10.1001/jama.2021.19623.
    PubMed         Abstract available
    
    
71. SAAD M, Kennedy KF, Imran H, Louis DW, et al
    Association Between COVID-19 Diagnosis and In-Hospital Mortality in Patients Hospitalized With ST-Segment Elevation Myocardial Infarction.
    JAMA. 2021 Oct 29. pii: 2785893. doi: 10.1001/jama.2021.18890.
    PubMed         Abstract available
    
    

    
    Lancet

72. COUSINS S
    Australian Commission calls for overhaul of aged care.
    Lancet. 2021;397:957.
    PubMed        
    
    
73. KAMPF G
    COVID-19: stigmatising the unvaccinated is not justified.
    Lancet. 2021;398:1871.
    PubMed        
    
    
74. HUANG L, Gu X, Cao B
    Long-term effects on survivors with COVID-19 - Authors' reply.
    Lancet. 2021;398:1872-1873.
    PubMed        
    
    
75. YANG C, Zhao H, Tebbutt SJ
    Long-term effects on survivors with COVID-19.
    Lancet. 2021;398:1872.
    PubMed        
    
    
76. ZHAO YJ, Bai W, Su Z, Ng CH, et al
    Long-term effects on survivors with COVID-19.
    Lancet. 2021;398:1871-1872.
    PubMed        
    
    

    
    N Engl J Med

77. ZARYCHANSKI R, Lawler PR, Goligher E
    Therapeutic Anticoagulation with Heparin in Patients with Covid-19. Reply.
    N Engl J Med. 2021;385:2014.
    PubMed        
    
    
78. FERNANDES TM, McGuire WC, Morris TA
    Therapeutic Anticoagulation with Heparin in Patients with Covid-19.
    N Engl J Med. 2021;385:2013.
    PubMed        
    
    
79. RUBIN EJ, Baden LR, Grinsztejn B, Morrissey S, et al
    Audio Interview: Covid-19 in Brazil and New Evidence for Vaccinating Younger Children.
    N Engl J Med. 2021;385:e79.
    PubMed        
    
    

    
    Pediatrics

80. BEERS LS, Szilagyi M, Seigel WM, Davis WS, et al
    Immunizing Against Hate: Overcoming Asian American and Pacific Islander Racism.
    Pediatrics. 2021;148.
    PubMed        
    
    
81. KEMPER AR, Hostutler CA, Beck K, Fontanella CA, et al
    Depression and Suicide-Risk Screening Results in Pediatric Primary Care.
    Pediatrics. 2021;148.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

82. GUERSTEIN S, Romeo-Aznar V, Dekel M, Miron O, et al
    The interplay between vaccination and social distancing strategies affects COVID19 population-level outcomes.
    PLoS Comput Biol. 2021;17:e1009319.
    PubMed         Abstract available
    
    
83. ZUVANOV L, Basso Garcia AL, Correr FH, Bizarria R Jr, et al
    The experience of teaching introductory programming skills to bioscientists in Brazil.
    PLoS Comput Biol. 2021;17:e1009534.
    PubMed         Abstract available
    
    
84. KING SB, Singh M
    Comparative genomic analysis reveals varying levels of mammalian adaptation to coronavirus infections.
    PLoS Comput Biol. 2021;17:e1009560.
    PubMed         Abstract available
    
    
85. WERTHEIM KY, Puniya BL, La Fleur A, Shah AR, et al
    A multi-approach and multi-scale platform to model CD4+ T cells responding to infections.
    PLoS Comput Biol. 2021;17:e1009209.
    PubMed         Abstract available
    
    

    
    PLoS One

86. EJIGU BA, Asfaw MD, Cavalerie L, Abebaw T, et al
    Assessing the impact of non-pharmaceutical interventions (NPI) on the dynamics of COVID-19: A mathematical modelling study of the case of Ethiopia.
    PLoS One. 2021;16:e0259874.
    PubMed         Abstract available
    
    
87. MIHELIC A, Jelovcan L, Prislan K
    Internal and external drivers for compliance with the COVID-19 preventive measures in Slovenia: The view from general deterrence and protection motivation.
    PLoS One. 2021;16:e0259675.
    PubMed         Abstract available
    
    
88. TURSKA E, Stepien-Lampa N
    Well-being of Polish university students after the first year of the coronavirus pandemic: The role of core self-evaluations, social support and fear of COVID-19.
    PLoS One. 2021;16:e0259296.
    PubMed         Abstract available
    
    
89. SERRA FE, Francisco RPV, de Rossi P, de Lourdes Brizot M, et al
    COVID-19 outcomes in hospitalized puerperal, pregnant, and neither pregnant nor puerperal women.
    PLoS One. 2021;16:e0259911.
    PubMed         Abstract available
    
    
90. SINCLAIR DR, Maharani A, Stow D, Welsh CE, et al
    Can vaccination roll-out be more equitable if population risk is taken into account?
    PLoS One. 2021;16:e0259990.
    PubMed         Abstract available
    
    
91. BRADFIELD Z, Wynter K, Hauck Y, Sweet L, et al
    COVID-19 vaccination perceptions and intentions of maternity care consumers and providers in Australia.
    PLoS One. 2021;16:e0260049.
    PubMed         Abstract available
    
    
92. SNYDER RL, Anderson LE, White KA, Tavitian S, et al
    A qualitative assessment of factors affecting nursing home caregiving staff experiences during the COVID-19 pandemic.
    PLoS One. 2021;16:e0260055.
    PubMed         Abstract available
    
    
93. LI X, English AS, Kulich SJ
    Anger among Chinese migrants amid COVID-19 discrimination: The role of host news coverage, cultural distance, and national identity.
    PLoS One. 2021;16:e0259866.
    PubMed         Abstract available
    
    
94. CLOER C, Roudsari L, Rochelle L, Petrie T, et al
    Mesenchymal stromal cell-derived extracellular vesicles reduce lung inflammation and damage in nonclinical acute lung injury: Implications for COVID-19.
    PLoS One. 2021;16:e0259732.
    PubMed         Abstract available
    
    
95. HORVE PF, Dietz L, Northcutt D, Stenson J, et al
    Evaluation of a bioaerosol sampler for indoor environmental surveillance of Severe Acute Respiratory Syndrome Coronavirus 2.
    PLoS One. 2021;16:e0257689.
    PubMed         Abstract available
    
    
96. DENG H, Du J, Gao J, Wang Q, et al
    Network percolation reveals adaptive bridges of the mobility network response to COVID-19.
    PLoS One. 2021;16:e0258868.
    PubMed         Abstract available
    
    
97. JAFAR A, Lasso A, Shorr R, Hutton B, et al
    Olfactory recovery following infection with COVID-19: A systematic review.
    PLoS One. 2021;16:e0259321.
    PubMed         Abstract available
    
    
98. DECKER MR, Wood SN, Thiongo M, Byrne ME, et al
    Gendered health, economic, social and safety impact of COVID-19 on adolescents and young adults in Nairobi, Kenya.
    PLoS One. 2021;16:e0259583.
    PubMed         Abstract available
    
    
99. LEULSEGED TW, Hassen IS, Maru EH, Zewsde WC, et al
    Characteristics and outcome profile of hospitalized African patients with COVID-19: The Ethiopian context.
    PLoS One. 2021;16:e0259454.
    PubMed         Abstract available
    
    
100. CHEVALERE J, Cazenave L, Berthon M, Martinez R, et al
     Computer-assisted instruction versus inquiry-based learning: The importance of working memory capacity.
     PLoS One. 2021;16:e0259664.
     PubMed         Abstract available
     
     
101. KUMAR NP, Padmapriyadarsini C, Rajamanickam A, Bhavani PK, et al
     BCG vaccination induces enhanced frequencies of memory T cells and altered plasma levels of common gammac cytokines in elderly individuals.
     PLoS One. 2021;16:e0258743.
     PubMed         Abstract available
     
     
102. KATSUMATA Y, Sano M, Okawara H, Sawada T, et al
     Laminar flow ventilation system to prevent airborne infection during exercise in the COVID-19 crisis: A single-center observational study.
     PLoS One. 2021;16:e0257549.
     PubMed         Abstract available
     
     
103. STAHL EC, Gopez AR, Tsuchida CA, Fan VB, et al
     LuNER: Multiplexed SARS-CoV-2 detection in clinical swab and wastewater samples.
     PLoS One. 2021;16:e0258263.
     PubMed         Abstract available
     
     
104. OLIVER KH, Keeton C, Chalkley R, Bowman E, et al
     Virtual Vanderbilt Summer Science Academy highlighted the opportunity to impact early STEMM students career knowledge through narrative.
     PLoS One. 2021;16:e0258660.
     PubMed         Abstract available
     
     
105. TOTH DJA, Beams AB, Keegan LT, Zhang Y, et al
     High variability in transmission of SARS-CoV-2 within households and implications for control.
     PLoS One. 2021;16:e0259097.
     PubMed         Abstract available
     
     
106. STYRA R, Hawryluck L, Mc Geer A, Dimas M, et al
     Surviving SARS and living through COVID-19: Healthcare worker mental health outcomes and insights for coping.
     PLoS One. 2021;16:e0258893.
     PubMed         Abstract available
     
     
107. GRANT BD, Anderson CE, Alonzo LF, Garing SH, et al
     A SARS-CoV-2 coronavirus nucleocapsid protein antigen-detecting lateral flow assay.
     PLoS One. 2021;16:e0258819.
     PubMed         Abstract available
     
     
108. HUNTER-SCHLICHTING D, Kelsey KT, Demmer R, Patel M, et al
     Cytomegalovirus infection in malignant pleural mesothelioma.
     PLoS One. 2021;16:e0254136.
     PubMed         Abstract available
     
     
109. KERIMOV D, Tamminen P, Viskari H, Lehtimaki L, et al
     Sampling site for SARS-CoV-2 RT-PCR-An intrapatient four-site comparison from Tampere, Finland.
     PLoS One. 2021;16:e0260184.
     PubMed         Abstract available
     
     
110. CHARTIER KG, Guidry JPD, Lee CA, Buckley TD, et al
     At home and online during the early months of the COVID-19 pandemic and the relationship to alcohol consumption in a national sample of U.S. adults.
     PLoS One. 2021;16:e0259947.
     PubMed         Abstract available
     
     
111. BRUBAKER J, Kilic T, Wollburg P
     Representativeness of individual-level data in COVID-19 phone surveys: Findings from Sub-Saharan Africa.
     PLoS One. 2021;16:e0258877.
     PubMed         Abstract available
     
     
112. SCHNEIDER CR, Freeman ALJ, Spiegelhalter D, van der Linden S, et al
     The effects of quality of evidence communication on perception of public health information about COVID-19: Two randomised controlled trials.
     PLoS One. 2021;16:e0259048.
     PubMed         Abstract available
     
     
113. JIANG Y, Duffy F, Hadlock J, Raappana A, et al
     Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection.
     PLoS One. 2021;16:e0259902.
     PubMed         Abstract available
     
     
114. LOPES-JUNIOR LC, Siqueira PC, Maciel ELN
     School reopening and risks accelerating the COVID-19 pandemic: A systematic review and meta-analysis protocol.
     PLoS One. 2021;16:e0260189.
     PubMed         Abstract available
     
     
115. LUCCHINI M, Gerosa T, Pancheva M, Pisati M, et al
     Differential effects of COVID-19 and containment measures on mental health: Evidence from ITA.LI-Italian Lives, the Italian household panel.
     PLoS One. 2021;16:e0259989.
     PubMed         Abstract available
     
     

     
     Proc Natl Acad Sci U S A

116. BALISTRERI G, Yamauchi Y, Teesalu T
     A widespread viral entry mechanism: The C-end Rule motif-neuropilin receptor interaction.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed         Abstract available
     
     
117. LOPEZ N, Del Debbio L, Baaden M, Praprotnik M, et al
     Lessons learned from urgent computing in Europe: Tackling the COVID-19 pandemic.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed         Abstract available
     
     

     
     Vaccine

118. FAN S, Li D, Zhao H, Yu L, et al
     Ameliorated immunity elicited by intradermal inoculation in individuals vaccinated with inactivated SARS-CoV-2 vaccine.
     Vaccine. 2021 Oct 22. pii: S0264-410X(21)01375.
     PubMed         Abstract available
     
     
119. GARCIA-GRIMSHAW M, Ceballos-Liceaga SE, Michel-Chavez A, Garcia-Alanis M, et al
     Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study.
     Vaccine. 2021 Oct 29. pii: S0264-410X(21)01391.
     PubMed         Abstract available
     
     
120. MUSCATELLO DJ, Nazareno AL, Turner RM, Newall AT, et al
     Influenza-associated mortality in Australia, 2010 through 2019: High modelled estimates in 2017.
     Vaccine. 2021 Nov 19. pii: S0264-410X(21)01464.
     PubMed         Abstract available
     
     
121. ORTEGA-SANCHEZ IR, Mott JA, Kittikraisak W, Khanthamaly V, et al
     Cost-effectiveness of seasonal influenza vaccination in pregnant women, healthcare workers and adults >= 60 years of age in Lao People's Democratic Republic.
     Vaccine. 2021 Nov 18. pii: S0264-410X(21)01445.
     PubMed         Abstract available
     
     
122. IRVING SA, Ball SW, Booth SM, Regan AK, et al
     A multi-country investigation of influenza vaccine coverage in pregnant individuals, 2010-2016.
     Vaccine. 2021 Nov 18. pii: S0264-410X(21)01463.
     PubMed         Abstract available
     
     
123. KHOURY J, Najjar-Debbiny R, Hanna A, Jabbour A, et al
     COVID-19 vaccine - Long term immune decline and breakthrough infections.
     Vaccine. 2021 Oct 30. pii: S0264-410X(21)01370.
     PubMed         Abstract available
     
     
124. CHAPIN-BARDALES J, Myers T, Gee J, Shay DK, et al
     Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system.
     Vaccine. 2021 Oct 16. pii: S0264-410X(21)01339.
     PubMed         Abstract available
     
     
125. GORDON SF, Clothier HJ, Morgan H, Buttery JP, et al
     Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia.
     Vaccine. 2021 Oct 29. pii: S0264-410X(21)01350.
     PubMed         Abstract available
     
     
126. MAKOVITZKI A, Lerer E, Kafri Y, Adar Y, et al
     Evaluation of a downstream process for the recovery and concentration of a Cell-Culture-Derived rVSV-Spike COVID-19 vaccine candidate.
     Vaccine. 2021 Oct 22. pii: S0264-410X(21)01376.
     PubMed         Abstract available
     
     
127. OLANIPEKUN T, Abe T, Effoe V, Westney G, et al
     Changes in COVID-19 vaccine acceptance rate among recovered critically Ill patients: A 12-month follow-up study.
     Vaccine. 2021 Oct 25. pii: S0264-410X(21)01324.
     PubMed         Abstract available
     
     
128. LIU H, Zhou C, An J, Song Y, et al
     Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants.
     Vaccine. 2021 Oct 30. pii: S0264-410X(21)01399.
     PubMed         Abstract available
     
     
129. BYRNE T, Patel P, Shrotri M, Beale S, et al
     Trends, patterns and psychological influences on COVID-19 vaccination intention: Findings from a large prospective community cohort study in England and Wales (Virus Watch).
     Vaccine. 2021 Oct 8. pii: S0264-410X(21)01281.
     PubMed         Abstract available
     
     
130. MALTEZOU HC, Panagopoulos P, Sourri F, Giannouchos TV, et al
     COVID-19 vaccination significantly reduces morbidity and absenteeism among healthcare personnel: A prospective multicenter study.
     Vaccine. 2021 Oct 30. pii: S0264-410X(21)01387.
     PubMed         Abstract available
     
     
131. CASSONE A, Cauda R
     Multicomponent vaccines to fight SARS-CoV-2 variants of concern.
     Vaccine. 2021 Nov 1. pii: S0264-410X(21)01402.
     PubMed        
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: